Cara Therapeutics, Inc. (NASDAQ:CARA) Receives Average Recommendation of “Hold” from Analysts
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) has been assigned an average recommendation of “Hold” from the five ratings firms that are presently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating. The average 12 month target price among brokers that have issued ratings on […]
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) has been assigned an average recommendation of “Hold” from the five ratings firms that are presently covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold rating. The average 12 month target price among brokers that have issued ratings on […]